These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 10859723)
21. Favorable effect of gamma-radiation for in-stent restenosis: effect of diabetes on angiographic and clinical outcomes. Iakovou I; Mehran R; Dangas G; Lansky AJ; Stone GW; Mintz GS; Aymong E; Ashby DT; Pichard AD; Satler LF; Kent K; Leon MB; Waksman R Catheter Cardiovasc Interv; 2004 Jul; 62(3):303-7. PubMed ID: 15224295 [TBL] [Abstract][Full Text] [Related]
22. A randomized, double-blind, placebo-controlled trial of abciximab for prevention of in-stent restenosis in diabetic patients after coronary stenting: results of the ASIAD (Abciximab in Stenting Inhibits restenosis Among Diabetics) Trial. Chen WH; Kaul U; Leung SK; Lau YK; Tan HC; Leung AW; Lee MK; Li SK; Ng W; Lee PY; Lam KF; Tse HF; Lau CP J Invasive Cardiol; 2005 Oct; 17(10):534-8. PubMed ID: 16204748 [TBL] [Abstract][Full Text] [Related]
23. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME; JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618 [TBL] [Abstract][Full Text] [Related]
24. [Catheter-based radiotherapy to inhibit restenosis after coronary stenting]. Sack H Strahlenther Onkol; 1998 Mar; 174(3):168. PubMed ID: 9524627 [No Abstract] [Full Text] [Related]
25. Radiation vascular therapy: a novel approach to preventing restenosis. Williams DO Am J Cardiol; 1998 Apr; 81(7A):18E-20E. PubMed ID: 9551590 [TBL] [Abstract][Full Text] [Related]
26. A subgroup analysis of the Scripps Coronary Radiation to Inhibit Proliferation Poststenting Trial. Teirstein PS; Massullo V; Jani S; Popma JJ; Mintz GS; Russo RJ; Schatz RA; Guarneri EM; Steuterman S; Cloutier DA; Leon MB; Tripuraneni P Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1097-104. PubMed ID: 9869235 [TBL] [Abstract][Full Text] [Related]
36. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP; JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102 [TBL] [Abstract][Full Text] [Related]
37. Vascular brachytherapy with 192Ir after femoropopliteal stent implantation in high-risk patients: twelve-month follow-up results from the Vienna-5 trial. Wolfram RM; Budinsky AC; Pokrajac B; Pötter R; Minar E Radiology; 2005 Jul; 236(1):343-51. PubMed ID: 15987985 [TBL] [Abstract][Full Text] [Related]
38. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. Windecker S; Remondino A; Eberli FR; Jüni P; Räber L; Wenaweser P; Togni M; Billinger M; Tüller D; Seiler C; Roffi M; Corti R; Sütsch G; Maier W; Lüscher T; Hess OM; Egger M; Meier B N Engl J Med; 2005 Aug; 353(7):653-62. PubMed ID: 16105989 [TBL] [Abstract][Full Text] [Related]
39. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Mahaffey KW; Cutlip DE; Fitzgerald PJ; Sood P; Su X; Lansky AJ; JAMA; 2008 Apr; 299(16):1903-13. PubMed ID: 18430909 [TBL] [Abstract][Full Text] [Related]